Chai Discovery：AI制药工具迎来质变，从科学转向工程
原标题：🔬The BioAI Phase Shift - Matthew McPartlon & Neil Patil, Chai Discovery
AI 摘要
在2025年1月的JPM制药大会上，OpenAI支持的初创公司Chai Discovery（估值40亿美元）宣布了多项大型AI制药工具交易，包括与礼来、诺华和argenx的合作。联合创始人Matt McPartlon和产品负责人Neil Patil在播客中表示，AI模型质量的提升使制药公司信任这些工具，从而解锁了药物发现的新能力，将科学转变为工程。Chai通过紧密合作和产品优化（如分子编辑器）实现了快速迭代，并强调好的技术是必要条件但非充分条件。
正文节选
This January, four big AI × Pharma tools deals were announced at the huge JPM Pharma conference that takes over San Francisco every year. OpenAI-backed Chai Discovery (now worth $4B) was somehow at the heart despite being all of 2 years old. The Science team is proud to bring you the first podcast with cofounder Matt McPartlon and product lead Neil Patil to tell the full story! Editor’s note: not to be confused with Chai AI, which was another top pod of ours. Pharma suddenly doing big AI tools d